Upcoming Earnings, Presentation of Clinical Data, Dividends, and Technical Updates - Research Reports on Achillion, KB Home, Hovnanian, QEP Resources and Fortune Brands

NEW YORK, October 17, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), KB Home (NYSE: KBH), Hovnanian Enterprises Inc. (NYSE: HOV), QEP Resources, Inc. (NYSE: QEP) and Fortune Brands Home & Security, Inc. (NYSE: FBHS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7277-100free.

--
Achillion Pharmaceuticals, Inc. Research Reports
On October 8, 2014, Achillion Pharmaceuticals, Inc. (Achillion) announced that it will present four abstracts at The Liver Meeting 2014, the 65th Annual Meeting of The American Association for the Study of Liver Diseases (AASLD), in Boston, to be held from November 7 - November 11, 2014. According to Achillion, a late breaker poster presentation will be made by the Company in the meeting, providing updated results, including SVR12, from an ongoing Phase 2 proxy study evaluating ACH-3102, Achillion's second-generation NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for eight weeks of treatment in patients with treatment-naïve genotype 1 chronic hepatitis C virus (HCV) infection. David Apelian, M.D., Ph.D., Executive Vice Present and Chief Medical Officer, commented, "We are delighted that Achillion's ongoing research into HCV with ACH-3102 will be featured in a late breaker poster presentation during the 2014 Liver Meeting. Furthermore, as we work to complete the Phase 1 trial of ACH-3422, we are pleased to have the opportunity to present new preclinical research detailing the profile of ACH-3422." The full research reports on Achillion are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/ACHN/report.pdf

--
KB Home Research Reports
On October 9, 2014, KB Home (KB Home) announced that its board of directors has declared a quarterly cash dividend of $.025 per share on the Company's common stock. According to the Company, the dividend will be payable on November 20, 2014 to stockholders of record as on November 6, 2014. The full research reports on KB Home are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/KBH/report.pdf

--
Hovnanian Enterprises Inc. Research Reports
On October 14, 2014, shares of Hovnanian Enterprises Inc. (Hovnanian) gained 5.8% to close the session at $3.28. The stock opened the session at $3.18 and fluctuated between $3.06 -$3.30 with a trading volume of 6.73 million, which is much higher than its 30 day-average volume of 2.92 million. YTD Hovnanian's stock has declined by 49.5% versus NYSE Composite that fell 2.1% during the same trading period. At the end of the day the 14-day RSI stood at 36.57, which suggests that the stock is very near to its oversold territory. The full research reports on Hovnanian are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/HOV/report.pdf

--
QEP Resources, Inc. Research Reports
On October 14, 2014, QEP Resources, Inc.'s (QEP Resources) stock fell 4.7% to close the session at $21.96. The stock opened the session at $23.27 and fluctuated between $21.87 -$23.42 with 7.70 million shares changing hands. During the session the stock hit a new 52-week low of $21.87. According to Zacks, a weak oil and gas pricing environment is the main reason behind the fall in energy stocks. Moreover, at the end of the session the stock closed below its 50-day and 200-day moving averages of $31.82 and $31.42 respectively. The full research reports on QEP Resources are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/QEP/report.pdf

--
Fortune Brands Home & Security, Inc. Research Reports
On October 8, 2014, Fortune Brands Home & Security, Inc. (Fortune Brands) announced that it will release its Q3 2014 financial results on October 29, 2014, after the market closes. Fortune Brands informed that on the same day at 4:30 p.m. ET, it will conduct a conference call to discuss the results. According to the Company, the call will be hosted by CEO, Chris Klein; CFO, Lee Wyatt; and Vice President of investor relations and corporate communications, Brian Lantz. The Company added that a live audio webcast of the conference call will be available on the events section of its website. The full research reports on Fortune Brands are available to download free of charge at:

http://www.analystsreview.com/Oct-17-2014/FBHS/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review